Amgen Inc (AMGN) operating KPIs
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)
Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%
Amgen dividends Paid Per Share (legacy quarterly disclosure) ($/sh) ($)
Form 10-Q Stockholders' Equity Note (XBRL)
Latest, Q4 2023
2.13
Period ended Dec 31, 2023
Change on a year earlier
+9.8%
1.94 in Q4 2022
History
36 quarters
Since Q1 2015
Sources
6
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Dividends Paid Per Share (legacy quarterly disclosure) ($/sh) ($) | Year on year | Source |
|---|---|---|---|---|
| Q4 2023 | Dec 31, 2023 | 2.13 | +9.8% | Form 10-K (filed 2024-02-14) ↗ |
| Q3 2023 | Sep 30, 2023 | 2.13 | +9.8% | Form 10-K (filed 2024-02-14) ↗ |
| Q2 2023 | Jun 30, 2023 | 2.13 | +9.8% | Form 10-K (filed 2024-02-14) ↗ |
| Q1 2023 | Mar 31, 2023 | 2.13 | +9.8% | Form 10-K (filed 2024-02-14) ↗ |
| Q4 2022 | Dec 31, 2022 | 1.94 | +10.2% | Form 10-K (filed 2024-02-14) ↗ |
| Q3 2022 | Sep 30, 2022 | 1.94 | +10.2% | Form 10-K (filed 2024-02-14) ↗ |
| Q2 2022 | Jun 30, 2022 | 1.94 | +10.2% | Form 10-K (filed 2024-02-14) ↗ |
| Q1 2022 | Mar 31, 2022 | 1.94 | +10.2% | Form 10-K (filed 2024-02-14) ↗ |
| Q4 2021 | Dec 31, 2021 | 1.76 | +10.0% | Form 10-K (filed 2024-02-14) ↗ |
| Q3 2021 | Sep 30, 2021 | 1.76 | +10.0% | Form 10-K (filed 2024-02-14) ↗ |
| Q2 2021 | Jun 30, 2021 | 1.76 | +10.0% | Form 10-K (filed 2024-02-14) ↗ |
| Q1 2021 | Mar 31, 2021 | 1.76 | +10.0% | Form 10-K (filed 2024-02-14) ↗ |
| Q4 2020 | Dec 31, 2020 | 1.60 | +10.3% | Form 10-K (filed 2023-02-09) ↗ |
| Q3 2020 | Sep 30, 2020 | 1.60 | +10.3% | Form 10-K (filed 2023-02-09) ↗ |
| Q2 2020 | Jun 30, 2020 | 1.60 | +10.3% | Form 10-K (filed 2023-02-09) ↗ |
| Q1 2020 | Mar 31, 2020 | 1.60 | +10.3% | Form 10-K (filed 2023-02-09) ↗ |
| Q4 2019 | Dec 31, 2019 | 1.45 | +9.8% | Form 10-K (filed 2022-02-16) ↗ |
| Q3 2019 | Sep 30, 2019 | 1.45 | +9.8% | Form 10-K (filed 2022-02-16) ↗ |
| Q2 2019 | Jun 30, 2019 | 1.45 | +9.8% | Form 10-K (filed 2022-02-16) ↗ |
| Q1 2019 | Mar 31, 2019 | 1.45 | +9.8% | Form 10-K (filed 2022-02-16) ↗ |
| Q4 2018 | Dec 31, 2018 | 1.32 | +14.8% | Form 10-K (filed 2021-02-09) ↗ |
| Q3 2018 | Sep 30, 2018 | 1.32 | +14.8% | Form 10-K (filed 2021-02-09) ↗ |
| Q2 2018 | Jun 30, 2018 | 1.32 | +14.8% | Form 10-K (filed 2021-02-09) ↗ |
| Q1 2018 | Mar 31, 2018 | 1.32 | +14.8% | Form 10-K (filed 2021-02-09) ↗ |
| Q4 2017 | Dec 31, 2017 | 1.15 | +15.0% | Form 10-K (filed 2019-02-13) ↗ |
| Q3 2017 | Sep 30, 2017 | 1.15 | +15.0% | Form 10-K (filed 2019-02-13) ↗ |
| Q2 2017 | Jun 30, 2017 | 1.15 | +15.0% | Form 10-K (filed 2019-02-13) ↗ |
| Q1 2017 | Mar 31, 2017 | 1.15 | +15.0% | Form 10-K (filed 2019-02-13) ↗ |
| Q4 2016 | Dec 31, 2016 | 1 | +26.6% | Form 10-K (filed 2019-02-13) ↗ |
| Q3 2016 | Sep 30, 2016 | 1 | +26.6% | Form 10-K (filed 2019-02-13) ↗ |
| Q2 2016 | Jun 30, 2016 | 1 | +26.6% | Form 10-K (filed 2019-02-13) ↗ |
| Q1 2016 | Mar 31, 2016 | 1 | +26.6% | Form 10-K (filed 2019-02-13) ↗ |
| Q4 2015 | Dec 31, 2015 | 0.79 | – | Form 10-K (filed 2018-02-13) ↗ |
| Q3 2015 | Sep 30, 2015 | 0.79 | – | Form 10-K (filed 2018-02-13) ↗ |
| Q2 2015 | Jun 30, 2015 | 0.79 | – | Form 10-K (filed 2018-02-13) ↗ |
| Q1 2015 | Mar 31, 2015 | 0.79 | – | Form 10-K (filed 2018-02-13) ↗ |
Cite this data
StockData. (2026). Amgen Dividends Paid Per Share (legacy quarterly disclosure) ($/sh) ($), quarterly Q1 2015–Q4 2023 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/div_paid_ps
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.